![Tratamiento con betabloqueantes en pacientes con disfunción sistólica ventricular pulmonar obstructiva crónica en medio ambulatorio Tratamiento con betabloqueantes en pacientes con disfunción sistólica ventricular pulmonar obstructiva crónica en medio ambulatorio](https://scielo.isciii.es/img/revistas/pharmacy/v7n4/205-212_03.gif)
Tratamiento con betabloqueantes en pacientes con disfunción sistólica ventricular pulmonar obstructiva crónica en medio ambulatorio
![SciELO - Brasil - Efeitos do tartarato de metoprolol em pacientes portadores de insuficiência cardíaca Efeitos do tartarato de metoprolol em pacientes portadores de insuficiência cardíaca SciELO - Brasil - Efeitos do tartarato de metoprolol em pacientes portadores de insuficiência cardíaca Efeitos do tartarato de metoprolol em pacientes portadores de insuficiência cardíaca](https://minio.scielo.br/documentstore/1678-4170/Y6BksFWk5sGwyqMK7Fr7Gdh/6c402ec2f3b2806336b9a65f2ebac70e866835a8.gif)
SciELO - Brasil - Efeitos do tartarato de metoprolol em pacientes portadores de insuficiência cardíaca Efeitos do tartarato de metoprolol em pacientes portadores de insuficiência cardíaca
![Comprehensive Comparative Effectiveness and Safety of First-Line β-Blocker Monotherapy in Hypertensive Patients | Hypertension Comprehensive Comparative Effectiveness and Safety of First-Line β-Blocker Monotherapy in Hypertensive Patients | Hypertension](https://www.ahajournals.org/cms/asset/c13cbce0-37c4-4dc9-9df5-f3a87c83682b/hypertensionaha.120.16402.fig05.jpg)
Comprehensive Comparative Effectiveness and Safety of First-Line β-Blocker Monotherapy in Hypertensive Patients | Hypertension
![Restoring the upward trend in blood pressure control rates in the United States: a focus on fixed-dose combinations | Journal of Human Hypertension Restoring the upward trend in blood pressure control rates in the United States: a focus on fixed-dose combinations | Journal of Human Hypertension](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41371-020-0340-6/MediaObjects/41371_2020_340_Fig1_HTML.png)
Restoring the upward trend in blood pressure control rates in the United States: a focus on fixed-dose combinations | Journal of Human Hypertension
![Table 1 from Tolerability and Feasibility of Beta-Blocker Titration in HFpEF Versus HFrEF: Insights From the CIBIS-ELD Trial. | Semantic Scholar Table 1 from Tolerability and Feasibility of Beta-Blocker Titration in HFpEF Versus HFrEF: Insights From the CIBIS-ELD Trial. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/67c0797707e78e220989e461b8072db79ed1fb0a/5-Table1-1.png)
Table 1 from Tolerability and Feasibility of Beta-Blocker Titration in HFpEF Versus HFrEF: Insights From the CIBIS-ELD Trial. | Semantic Scholar
Switching to once-daily evidence-based [beta]-blockers in patients with systolic heart failure or left ventricular dysfunction after myocardial infarction - Document - Gale Academic OneFile
![WO2017182754A1 - Pharmaceutical composition comprising a beta blocker, a converting enzyme inhibitor and an antihypertensive or an nsaid - Google Patents WO2017182754A1 - Pharmaceutical composition comprising a beta blocker, a converting enzyme inhibitor and an antihypertensive or an nsaid - Google Patents](https://patentimages.storage.googleapis.com/6a/8a/05/46fe72d4638236/imgf000005_0001.png)
WO2017182754A1 - Pharmaceutical composition comprising a beta blocker, a converting enzyme inhibitor and an antihypertensive or an nsaid - Google Patents
![Comparison of bisoprolol to a metoprolol CR/ZOK tablet for control of heart rate and blood pressure in mild-to-moderate hypertensive patients: the CREATIVE study | Hypertension Research Comparison of bisoprolol to a metoprolol CR/ZOK tablet for control of heart rate and blood pressure in mild-to-moderate hypertensive patients: the CREATIVE study | Hypertension Research](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fhr.2016.101/MediaObjects/41440_2017_Article_BFhr2016101_Fig1_HTML.jpg)
Comparison of bisoprolol to a metoprolol CR/ZOK tablet for control of heart rate and blood pressure in mild-to-moderate hypertensive patients: the CREATIVE study | Hypertension Research
![Beta-blockade with Bisoprolol Linked with Higher Mortality Benefits in Heart Failure Patients with Diabetes - Metabolic Health Digest Beta-blockade with Bisoprolol Linked with Higher Mortality Benefits in Heart Failure Patients with Diabetes - Metabolic Health Digest](https://www.metabolichealthdigest.com/wp-content/uploads/2021/08/Article-10-Graph-2.jpg)
Beta-blockade with Bisoprolol Linked with Higher Mortality Benefits in Heart Failure Patients with Diabetes - Metabolic Health Digest
![Betaxolol is equivalent to carvedilol in patients with heart failure NYHA II or III: Result of a randomized multicenter trial (BETACAR Trial) - ScienceDirect Betaxolol is equivalent to carvedilol in patients with heart failure NYHA II or III: Result of a randomized multicenter trial (BETACAR Trial) - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S016752730500882X-fx1.jpg)
Betaxolol is equivalent to carvedilol in patients with heart failure NYHA II or III: Result of a randomized multicenter trial (BETACAR Trial) - ScienceDirect
![Table 5 from Impact of carvedilol and metoprolol on inappropriate implantable cardioverter-defibrillator therapy: the MADIT-CRT trial (Multicenter Automatic Defibrillator Implantation With Cardiac Resynchronization Therapy). | Semantic Scholar Table 5 from Impact of carvedilol and metoprolol on inappropriate implantable cardioverter-defibrillator therapy: the MADIT-CRT trial (Multicenter Automatic Defibrillator Implantation With Cardiac Resynchronization Therapy). | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/756f1a156300486fff78e90803b94ee14c5b9b76/7-Table5-1.png)